{"disease":{"id":"ventricular-arrhythmias","name":"ventricular arrhythmias"},"drugs":{"marketed":[{"drug_id":"flecainide","indication_name":"Documented Ventricular Arrhythmias","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tambocor","generic_name":"FLECAINIDE","company_name":"","drug_phase":"marketed","molecular_target":"Potassium voltage-gated channel subfamily H member 2","drug_class":"Antiarrhythmic","quality_score":59,"revenue":null,"mechanism":""},{"drug_id":"mexiletine","indication_name":"Ventricular Arrhythmias","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mexitil","generic_name":"MEXILETINE","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2B","drug_class":"Antiarrhythmic","quality_score":66,"revenue":null,"mechanism":"Mexitil works by blocking abnormal electrical signals in the heart to restore a normal heartbeat."},{"drug_id":"mexiletine-hydrochloride","indication_name":"Ventricular Arrhythmias","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"MEXILETINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"sodium channels","drug_class":"","quality_score":53,"revenue":null,"mechanism":"Mexiletine, an oral antiarrhythmic, reduces ventricular arrhythmias by inhibiting sodium currents and altering refractory periods."},{"drug_id":"flecainide-acetate","indication_name":"Documented Ventricular Arrhythmias","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"FLECAINIDE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":38,"revenue":null,"mechanism":null},{"drug_id":"norpace","indication_name":"Documented ventricular arrhythmias","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norpace Cr","generic_name":"Disopyramide Phosphate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"G protein-activated inward rectifier potassium channel 4","drug_class":"High Risk QT Prolonging Agents","quality_score":72,"revenue":null,"mechanism":"Norpace is a sodium channel blocker and a Class 1a anti-arrhythmic agent."},{"drug_id":"norpace","indication_name":"Life-threatening ventricular arrhythmias","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norpace Cr","generic_name":"Disopyramide Phosphate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"G protein-activated inward rectifier potassium channel 4","drug_class":"High Risk QT Prolonging Agents","quality_score":72,"revenue":null,"mechanism":"Norpace is a sodium channel blocker and a Class 1a anti-arrhythmic agent."}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06607471","title":"Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Scientific Institute San Raffaele","has_results":false},{"nct_id":"NCT07354347","title":"Optimal Settings for Anti Tachycardia Pacing (ATP) on ICD","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":3980,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT07291544","title":"Management of Supraventricular Tachycardias in Children","phase":"","overall_status":"COMPLETED","enrollment_count":1400,"lead_sponsor_name":"Paris Cardiovascular Research Center (Inserm U970)","has_results":false},{"nct_id":"NCT03833089","title":"Targeted Potassium Levels for Prevention of ICD Therapy","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT06835491","title":"Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":674,"lead_sponsor_name":"Versailles Hospital","has_results":false},{"nct_id":"NCT07077928","title":"Effects of Upgrading From Right Ventricular Pacing to Cardiac Resynchronization Therapy and Comparison With Dual-Chamber Defibrillator","phase":"","overall_status":"COMPLETED","enrollment_count":307,"lead_sponsor_name":"Bursa Postgraduate Hospital","has_results":false},{"nct_id":"NCT07103733","title":"PRIMARY Ancillary Substudy","phase":"NA","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Annetine Gelijns","has_results":false},{"nct_id":"NCT06281977","title":"Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":192,"lead_sponsor_name":"Ottawa Heart Institute Research Corporation","has_results":false},{"nct_id":"NCT03294278","title":"Epicardial Ablation in Brugada Syndrome to Prevent Sudden Death","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"IRCCS Policlinico S. Donato","has_results":false},{"nct_id":"NCT07121855","title":"Symptoms and Coping Strategies Among Patients With Implantable Cardioverter Defibrillator","phase":"","overall_status":"COMPLETED","enrollment_count":142,"lead_sponsor_name":"TC Erciyes University","has_results":false},{"nct_id":"NCT03665324","title":"Atrial Function and Supraventricular Arrhythmia of the Veteran Athlete.","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT06602635","title":"Hybrid Score to Predict OTVA-SOO in Patients with Wide Basal QRS","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Centro Medico Teknon","has_results":false},{"nct_id":"NCT02275104","title":"Multimodal Image Processing Software to Guide Cardiac Ablation Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT06360003","title":"\"Right Ventricular Outflow Tract Posterior Septum Pacing\" in Predicting Ventricular Outflow Tract Ventricular Tachycardia Origin","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Second Affiliated Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT04495712","title":"Antiarrhythmic Effects of Spironolactone in Patients With ICDs","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT07026695","title":"Transcutaneous Vagus Nerve Stimulation for Ventricular Arrhythmias","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":72,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT05643235","title":"Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Northwell Health","has_results":false},{"nct_id":"NCT06864429","title":"Impact of Catheter Ablation of Frequent Premature Ventricular Complexes in Treating Subtle Left Cardiomyopathy","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT07375264","title":"Cardiac Sympathetic Denervation in Patients With Refractory Arrhythmic Storm: a Single-center Case Series","phase":"","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Jose Manuel López González","has_results":false},{"nct_id":"NCT05084391","title":"Phase I/II Randomized Study of Stereotactic Ablative Radiotherapy (SABR) Versus Standard of Care for Refractory Structural Cardiac Arrhythmias (SABR-HEART)","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false}],"total":20},"guidelines":[],"source":"Drug Landscape verified database"}